ISABEL
CASTREJÓN FERNÁNDEZ
Profesora asociada
University of Bari Aldo Moro
Bari, ItaliaPublicaciones en colaboración con investigadores/as de University of Bari Aldo Moro (7)
2024
-
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries
Arthritis Care and Research, Vol. 76, Núm. 11, pp. 1558-1565
-
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study
RMD Open, Vol. 10, Núm. 3
-
Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice
Seminars in Arthritis and Rheumatism, Vol. 65
-
Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network
Arthritis and Rheumatology, Vol. 76, Núm. 4, pp. 587-598
2023
-
Commonalities and differences in set-up and data collection across European spondyloarthritis registries — results from the EuroSpA collaboration
Arthritis Research and Therapy, Vol. 25, Núm. 1
-
Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
The Lancet Regional Health - Europe, Vol. 33
-
Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: Results from the EuroSpA Research Collaboration Network
RMD Open, Vol. 9, Núm. 4